Quest Diagnostics Inc
- Stock
- Ticker DGX
- ISIN US74834L1008
- NYSE
Performance, volatility and drawdowns of Quest Diagnostics Inc since 11/2016, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.
Performance
$10,000 grew to $36,001. Global equities (VT): $29,042.
Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.
Declines from the peak
Lowest point −36.6% in 04/2020, measured from the peak in 03/2020. It took 2 months to get back to the old peak.
Financial statements
Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures
| Quarter end | 12/2024 | 03/2025 | 06/2025 | 09/2025 | 12/2025 | 03/2026 | 06/2026 | 09/2026 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | 2,621 | 2,652 | 2,761 | 2,816 | 2,806 | 2,895 | 3,043 | 3,097 |
| Gross profit | 858 | 863 | 943 | 949 | 910 | 942 | 1,027 | 1,042 |
| Operating income | 361 | 346 | 438 | 386 | 386 | 399 | 459 | 479 |
| EBITDA | 496 | 486 | 581 | 528 | 531 | 546 | 605 | 626 |
| Net income | 222 | 220 | 282 | 245 | 245 | 252 | 320 | 312 |
| Earnings per share | 1.95 | 1.94 | 2.47 | 2.16 | 2.18 | 2.24 | 2.84 | 2.78 |
| Balance sheet | ||||||||
| Total assets | 16,153 | 15,797 | 15,969 | 16,197 | 16,225 | 16,673 | 16,939 | 17,221 |
| Liabilities | 9,340 | 8,835 | 8,704 | 8,902 | 9,019 | 9,007 | 9,120 | 9,271 |
| Equity | 6,778 | 6,929 | 7,228 | 7,258 | 7,170 | 7,366 | 7,516 | 7,632 |
| Cash | 549 | 188 | 319 | 432 | 420 | 393 | 626 | 797 |
| Long-term debt | 5,615 | – | – | – | 5,167 | – | 5,632 | 5,540 |
| Cash flow | ||||||||
| Operating cash flow | 464 | 314 | 544 | 563 | 465 | 278 | 597 | 611 |
| Capital expenditure | -123 | -117 | -108 | -144 | -158 | -114 | -138 | -166 |
| Free cash flow | 341 | 197 | 436 | 419 | 307 | 164 | 459 | 445 |
Value it:DCF calculatorMultiples calculator
Annual returns
Best year 2021 at +47.9%, weakest 2018 at −13.8%. 6 of 9 full years were positive. * partial year.
Quarterly reports
Filing date with the SEC and earnings per share of the quarter
| Day | Earnings per share |
|---|---|
| 23 Oct 2026 | $2.78 |
| 23 Jul 2026 | $2.84 |
| 22 Apr 2026 | $2.24 |
| 26 Feb 2026 | $2.18 |
| 21 Oct 2025 | $2.16 |
| 23 Jul 2025 | $2.47 |
| 23 Apr 2025 | $1.94 |
| 20 Feb 2025 | $1.95 |
| 23 Oct 2024 | $1.99 |
| 24 Jul 2024 | $2.03 |
| 24 Apr 2024 | $1.72 |
| 22 Feb 2024 | $1.70 |
Key metrics
Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.
Valuation
- Market cap
- €26bn
- Market cap in trading currency
- $28.4bn
- Enterprise value
- $33.2bn
- P/E
- 25.7
- P/S
- 2.40
- P/B
- 3.72
- EV/Sales
- 2.80
- EV/EBITDA
- 14.4
- Earnings yield
- 3.9%
- FCF yield
- 4.8%
Results (last four quarters)
- Revenue
- $11.8bn
- Gross profit
- $3.92bn
- EBITDA
- $2.31bn
- Net income
- $1.13bn
- Earnings per share
- $10.04
- Revenue per share
- $107.63
- Revenue growth
- +10.0%
- Earnings growth
- +27.3%
Profitability
- Gross margin
- 33.1%
- Operating margin
- 14.6%
- Net margin
- 9.5%
- Return on equity
- 15.2%
- Return on assets
- 6.6%
Balance sheet and cash flow
- Cash
- $797m
- Cash per share
- $7.24
- Financial debt
- $5.55bn
- Debt/equity %
- 73
- Current ratio
- 1.70
- Book value per share
- $69.37
- Operating cash flow
- $1.95bn
- Free cash flow
- $1.38bn
Dividend
- Dividend yield
- 1.31%
- Dividend (12 months)
- $3.38
- Yield (12 months)
- 1.31%
- Payout ratio
- 34%
- Ex-dividend date
- 6 Oct 2026
Shares and trading
- Shares outstanding
- 110m
- Volume
- 1.37m
- Avg. volume 3 months
- 1.03m
- Relative volume
- 1.3
Price and technicals
- Price
- $258.28
- 1 day
- −0.3%
- 52-week high
- $262.21
- 52-week low
- $173.49
- Distance to 52-week high
- −1.5%
- Distance to 52-week low
- +48.9%
- Distance to 50-day line
- +6.0%
- Distance to 200-day line
- +18.8%
- RSI (14)
- 61
- Volatility 1M
- 20.8%
Performance
- 1 week
- −0.5%
- 1 month
- +6.2%
- 3 months
- +5.9%
- 6 months
- +32.3%
- YTD
- +48.8%
- 1 year
- +38.9%
Dates
- Fiscal year end
- 31 Dec 2025
- Most recent quarter
- 30 Sep 2026
Frequently asked questions
How has DGX performed since 11/2016?
$10,000 grew to $36,001 by 20 Nov 2026, which is +13.7% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.
How volatile is DGX?
Volatility was 25.9% per year, measured on monthly returns. The largest decline from a peak was −36.6%, with the low in 04/2020.
How does DGX compare with a broad equity ETF?
Over the same period Global equities (VT) returned +11.3% per year at 15.1% volatility, DGX returned +13.7% at 25.9%. The correlation of monthly returns was 0.45; 1 would mean they moved in lockstep.
Which currency are the figures in?
In US dollars, the currency of the US listing.